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Abstract 
Objectives: Current treatments of oral lichen planus are palliative, not curative. Because psychiatric disorders 
significantly influence the development and severity of oral lichen planus, the use of psychiatric drug therapy may 
be an adjunct in treatment. The purpose of this study was to determine the efficacy of drug therapy of psychiatric 
disorders in oral lichen planus. Study design: Our controlled clinical study consisted of forty-six patients with 
oral lichen planus and psychiatric disorders who were randomly divided into two groups. Both groups were given 
topical corticosteroids and the study group received additional psychiatric drug therapy. Patients were monitored 
for a period of 6 months. Response to treatment was evaluated in each group and was compared with the other 
group using Mann-Whitney tests. We evaluated the correlation between psychiatric disorders and the recovery 
of oral lesions using Spearman’s correlation coefficient analysis. Results: Decrease in the size of the lesions was 
significantly greater in the study group after six months, but this difference was not significant in relationship to 
the pain experienced and the kind of lesion. Spearman’s correlation coefficient analysis demonstrated that, in the 
sixth month, there was a significant and direct relationship between recovery from the psychiatric disorders and 
response to treatment of OLP lesions, particularly as it pertained to the kind of lesion. Conclusion: The present 
study indicates that the combination of psychiatric drug therapy and routine treatment methods were effective in 
reducing the size of the lesions, but did not have any significant effect on the symptoms.
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Introduction
Lichen planus is a relatively common chronic mucocu-
taneous disease. The disease has varied prevalence in 
different parts of the world but generally approximately 
1% of the world population suffer from skin lesions (1) 
and around 0.5-2.2% have the oral lesions (1,2). Ex-
act etiology of the disease is unknown, but it has been 
demonstrated that degeneration of the epithelial basal 
layer, resulting from a change in cell-mediated immune 
response, has a significant role in the pathogenicity of 
the lesion (3). Therefore, any factor that can influence 
the cell-mediated immune response can have a role in 
the development of the disease. Factors such as stress 
and psychological problems, especially depression and 
anxiety, have been mentioned as etiologic factors in li-
chen planus but there is still controversy concerning the 
role of stress as a major or minor etiologic factor in the 
pathogenicity of lichen planus (4-7). 
The correlation of this disease and psychiatric disor-
ders has been studied, but no research into the effect of 
psychiatric therapy on oral lichen planus patients has 
been carried out to date. In the present study we tried 
to evaluate psychiatric condition of our patients and the 
concomitant effect of the drug therapy of psychologi-
cal disorders and routine treatment modalities of lichen 
planus on oral lesions.
Material and Methods
A randomized clinical trial study was designed to eval-
uate the effect of the drug therapy of psychiatric disor-
ders on lichen planus. We filled out Special examination 
forms for 55 patients referring to the Oral Medicine De-
partment in Mashad Dental School from October 2004 
to December 2005 and oral lichen planus had been con-
firmed through clinical examination, biopsy and his-
topathological evaluation. Then the patients were evalu-
ated by a psychologist. Out of 55 patients, 53 patients 
were diagnosed with one of the psychological disorders 
according to the criteria set by DSM-IV-IR. (8). We ex-
plained the study procedure to the patients; then they 
filled out informed written consent forms. The subjects 
having the inclusion criteria were chosen for the study. 
Inclusion criteria
1) patients with oral lichen planus (all forms) with or 
without skin involvement;
2) affliction with psychiatric disorders. 
Exclusion criteria 
1) patients exhibiting dysplasia in histopathological 
evaluation (1 patient); 
2) patients with lichenoid reaction potential as evi-
denced by histopathological examination, drug intake 
or other predisposing conditions (5 patients); 
3) patients diagnosed with acute psychosis with the po-
tential of harming themselves or others (no patients);
4) patients who had received any medications for lichen 
planus during the past month (1 patient); 
Forty-six patients; 31 subjects from the case group and 
15 subjects from the control group were followed for 6 
months.
Location, form and size of the lesions and pain sensation 
of each patient were recorded in the questionnaires. 
The severity of the signs in lichen planus depends on the 
form and size of the lesions. Oral lesions were described 
and classified in 3 groups: (1) 
1) keratotic ( reticular form, plaque form or both).
2) atrophic (atrophic lesion with or without keratotic le-
sion).
3) erosive-bullous (erosive or bullous lesion with or 
without keratotic lesion).
The oral cavity was divided into ten areas to determine 
the percentage of lichen planus extension in the oral 
cavity. These areas were: oral vestibule, alveolar mu-
cosa, lips, buccal mucosa, oral floor, fauces, gingiva, 
palate and the dorsal and ventral aspects of the tongue. 
Therefore, the percentages of the involvement for all ar-
eas of the oral mucosa were calculated and subsequently 
the percentage of the involvement of the oral cavity was 
calculated (Fig, 1,2).
Fig. 1. patient No. 11. The 
patient in the case group had 
atrophy, erosion and mod-
erate keratosis on the up-
per lip mucosa and atrophy 
and mild keratosis on the 
mucosa of the anterior up-
per gingival (A). Complete 
recovery was observed after 
psychiatric and routine OLP 
treatment (B).
A
B
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The severity of pain and pain sensation was evaluated 
according to following scales:
Scale 0: no pain: VAS=0
Scale 1: mild pain: 0< VAS≤3.5
Scale 2: moderate pain: 3.5 <VAS≤7
Scale 3: severe pain: 7< VAS≤10 [1].
Both groups received routine treatment for oral lichen 
planus. This treatment regimen consisted of topical 
corticosteroids, mostly triamcinolone along with (anti-
fungal) nystatin. The case group received drug therapy 
for psychiatric disorders in addition to the routine treat-
ment for lichen planus. Then the patients were subjected 
to regular oral examinations every two weeks, carried 
out by an oral medicine specialist who was blinded to 
the treatment received by each patient, until the signs 
and symptoms were brought under control. The patients 
in the case group were evaluated for possible side ef-
fects of the medication(s) 2 weeks after the initiation of 
the study and afterwards were monthly examined by the 
psychologist, too. Treatment of patients continued until 
remission of signs and symptoms.
The recovery rate (response to treatment) in each patient 
was evaluated according to Tables 1 and 2, based on the 
percentage of the area involved, form of the lesion and 
the severity of the pain. 
The psychiatric recovery of the patients has been clas-
sified in Table 3. 
A
B
Fig. 2. patient No. 32. The patient in the case 
group had large ulcer and keratosis on the 
ventral of the tongue and floor of the mouth 
(A). Complete recovery was observed after 
psychiatric and routine OLP treatment (B).
Response to 
treatment Scale
Criteria for 
lesion form
Criteria for 
severity of pain
Excellent 0
conversion of 
scales  1,2 & 
3 to 0
(without lesion)
conversion of scales 
1,2 & 3 to 0
(without pain)
Good 1 conversion of scale  3 to 1
conversion of 
scale 3 to 1
Fair 2
conversion of 
scale  2 to 1
or conversion of 
scale 3 to 2
conversion of scale 
2 to 1
or 3 to 2
Poor 3 no conversion in scale no change in pain
exacerbation 4
conversion of 
scale  1 to 2 
or 3
or conversion of 
scale 2 to 3
conversion of sca-
le 0 to1 or 2 or 3
or conversion of 
scale 1 to 2 or 3
Scale Response to treatment
0 complete response
1 good response
2 little response
3 no response
Response to 
treatment Scale Criteria
excellent 0 recovery ≥ 75%
good 1 50% ≤ recovery < 75%
fair 2 25% ≤ recovery < 50%
poor 3 0% ≤ recovery < 25%
exacerbation 4 increase in lesion size and extension
Table 1. Scaling of response to OLP treatment as to lesion size and 
extension.
Table 3. The classification of the psy-
chological recovery of the patients.
Table 2. Scaling of response to OLP treatment as to the form of the 
lesion and severity of pain.
e325
Med Oral Patol Oral Cir Bucal. 2010 Mar 1;15 (2):e322-7.                                                                                                                                           Psychiatric drug therapy on oral lichen planus
The comparison of the case and control groups regard-
ing complete or partial response to treatment was car-
ried out in the second and sixth months according to the 
codes depicted in Tables 1 and 2. The results of the two 
groups as to the remission of the signs and symptoms of 
oral lichen planus were compared using the non-para-
metric Mann-Whitney test. 
Also, the patients in the case group were subjected to 
Spearman’s test to be evaluated in relation to the cor-
relation between psychological recovery and oral lesion 
recovery, given the size and form of the lesions and the 
pain sensation. 
The protocol of this study was approved by the Medical 
Ethics Panel of Mashad Medical Sciences University 
and all the patients were informed of all the procedures 
involved in the study and all had information about the 
anecdotal nature of the study. 
Results
The two groups were matched as to age, sex, lesion size, 
the severity of the pain of the lesion, number of psychi-
atric disorders and the type of psychiatric disorders.
Our study obtained the following results:
A: Comparison of response to treatment between the 
patients in two groups was evaluated according to:
Size of the lesions: (Table 4) demonstrates that the pa-
tients in the case group had given a better response to 
lichen planus treatment, i.e. the size of the lesions had 
decreased to different degrees and this difference in re-
sponse was significant in the sixth month (P=0.026).
Form of the lesions: According to Table 5, although there 
were differences in the response to treatment between the 
study group and the control group as to the conversion of 
severe symptomatic cases (erosive and atrophic) to milder 
cases (keratotic), these differences were not statistically 
significant in the sixth months (P=0.31).
Pain severity: According to Table 6, a higher proportion 
of patients in the case group had no pain or had mild 
pain in the sixth month compared to the patients in the 
control group. The difference was not statistically sig-
nificant in the sixth months (P= 0.476).
B: Correlation of response to treatment: 
Spearman’s correlation coefficient analysis demonstrated 
that, only, in the sixth month there was a significant and 
direct relationship between recovery from the psychiatric 
disorders and response to treatment of OLP lesions con-
cerning the form of the lesions (P=0.058, r=0.377). 
Month Six
Response to treatment Scale of response
Case Control
Number Percent Number Percent
excellent 0 6 19.4 0 0.0
good 1 8 25.8 4 26.7
fair 2 7 22.6 2 13.3
poor 3 8 25.8 4 26.7
exacerbation 4 2 6.5 5 33.3
                             Total 31 100 15 100
Month Six
Response to treatment Scale of response
Case Control
Number Percent Number Percent
excellent 0 0 0.0 0 0.0
good 1 4 12.9 2 13.3
fair 2 14 45.2 3 20.0
poor 3 11 35.5 10 66.7
exacerbation 4 2 6.5 0 0.0
                       Total 31 100 15 100
Table 4. The comparison of the response to treatment between the case and control groups as to lesion 
size in the sixth months.
Mann-Withney test.  Z=-2.22; P=0.026
Table 5. The comparison of response to treatment between the case and control groups as to the form of 
the lesions in the sixth months.
Mann-Withney test.  Z=-1.002; P=0.31
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Discussion
The results of the study demonstrated that a combina-
tion of psychotherapy and routine OLP treatment results 
in a more noticeable decrease in lesion size compared to 
routine OLP treatment alone. 
However, here is controversy over the role of stress as 
a possible etiologic factor in OLP (4,6,7); some studies 
have already been carried out on the role of psychiatric 
disorders and stress as etiologic factors in oral lichen 
planus. The vast majority of these studies have used 
Hamilton Anxiety Scale (HAS) and Hamilton Depres-
sion Scale (HDS) and Beck Depression Score (BDS) to 
compare anxiety and depression level of the patients 
suffering from OLP with a control group consisting of 
healthy subjects and some have detected a higher level 
of stress and depression in patients suffering from OLP 
(4,7,9). However, these studies were not interventional 
studies. Contrary to these studies the present study de-
termined the type of the psychiatric disorders through 
an interview with a psychologist and evaluated the ef-
fect of drug therapy of the disorders on the remission of 
OLP lesions. 
Contrary to the vast majority of earlier studies, which 
have only evaluated atrophic and erosive-bullous le-
sions (10), we incorporated keratotic lesions, too, into 
our study. Keratotic lesions do not respond well to rou-
tine treatment and the evaluation of the effect of psy-
chotherapy on these lesions is of utmost significance. 
The most important consideration in this study is de-
termining all psychotic disorders. These disorders con-
sisted of anxiety, mood, somatoform, adaptation, drug 
withdrawal and personality disorders. Nearly 93.22% of 
our patients, who had OLP, suffered from anxiety dis-
orders, 52.54% suffered from mood disorders, 10.16% 
had somatoform disorders and 1.17% had personality 
disorders. Some patients had several concomitant psy-
chiatric disorders.  The most common disorder among 
our patients was generalized anxiety disorder (GAD) 
Month Six
Response to treatment Scale of response
Case Control
Number Percent Number Percent
excellent 0 11 55.0 4 40.0
good 1 1 5.0 0 0.0
fair 2 3 15.0 2 20.0
poor 3 3 15.0 4 40.0
exacerbation 4 2 10.0 0 0.0
Total 20 100 10 100
Table 6. The comparison of response to treatment between the control and case groups as to the sever-
ity of pain in the sixth months.
Mann-Withney test. Z=-0.712; P=0.476
with a prevalence of 54.32%; major depression disorder 
ranked second with a prevalence of 35.59% and only 
5.08% of the patients did not have any psychiatric disor-
der, which is consistent with the results of a study car-
ried out by Collela, who had observed a higher level of 
anxiety and depression in OLP patients compared to a 
control group (9). Chaudhary concluded from a study 
in 2004 that OLP patients have a higher level of stress, 
anxiety and depression compared to healthy individuals 
(11). The level of depression observed in our patients 
was comparable to the level observed by Akay, who re-
ported depression in 53% of the patients suffering from 
OLP (4). 
Another important consideration in the current study 
was the fact that in some patients the condition exacer-
bated regarding lesion size, form of the lesions, pain as 
soon as they were subjected to a certain kind of stress 
during the study period. Such stressors consisted of 
family members’ disease, financial or legal problems, 
cancerophobia, and family disagreements (a second 
marriage of the husband, marriage of children despite 
parents’ opposition, lack of understanding between 
spouses), loneliness, worries concerning childbirth, ac-
cidents, assault and battery and death of family members 
and relatives. However, some studies have demonstrated 
that stress may not result in OLP development but OLP 
may alter the individual’s self-image and influence his/
her public relations and lead to secondary depression 
(4). Some other studies have failed to establish a direct 
cause-and-affect relationship between psychiatric dis-
orders and lichen planus (6). In addition, although there 
seemed to be a parallel relationship between the general 
response to psychotherapy and the general response to 
OLP treatment in the case group, we were not able to 
substantiate this using Spearman’s analysis of correla-
tion coefficient. 
Generally, it may be concluded that although the current 
study has failed to statistically and decisively establish 
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the key role of psychotherapy, especially the drug ther-
apy of these conditions, in the treatment of oral lichen 
planus, our observation concerning the exacerbation of 
the signs and symptoms of the lesions concomitant with 
stressful  experiences of the patients during study peri-
od and the effect of psychotherapy in reduction of lesion 
size indicated that psychotherapy can be used, at least 
as an adjunct to routine OLP treatment, to minimize the 
use of topical and systemic corticosteroids, since topi-
cal corticosteroids have various local side effects, in-
cluding oral candidiasis and xerostomia and widespread 
systemic side effects such as hypertension, tachycardia, 
peptic ulcer, gastritis, edema and an increase in appe-
tite, restricting their use (12). 
Studies on the effect of psychotherapy alone (drug ther-
apy and non-drug therapy) on lichen planus lesions, per-
sonality assessment and determining stress level during 
examination may help determine the role of psychother-
apy in this condition. 
Conclusion
The present study on the effect of drug therapy of psy-
chiatric disorders on OLP indicates that psychiatric treat-
ment, along with routine OLP treatment, can be effective 
in reducing the size of the lesions. Therefore, psychiatric 
treatment of the patients along with routine treatment of 
oral lichen planus lesions, is recommended. 
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